A drug to treat a life-threatening form of leukemia has gained federal approval.
Tasigna, known generically as nilotinib, won approval to treat chronic and accelerated phase Philadelphia chromosome-positive, chronic myeloid leukemia, a form of the blood cancer. FDA approval is specifically for use in patients who are resistant or intolerant to previous treatment, including with another drug called Gleevec also made by the Swiss pharmaceutical company Novartis AG.
Representatives of the Israeli Defence Ministry responded to recent reports about the possible delivery of S-300 SAM systems from Russia to Syria. Israeli Defence Minister Avigdor Lieberman said that Israel would destroy those systems
Russia is to start supplying S-300 air defence systems to Syria in the near future. The shipments will be conducted free of charge